Output: Research to Practice
Historically, NIOSH has been a leader in applying research into workplace solutions that reduce injury and illness. Research to Practice (r2p) is a NIOSH initiative focused on the transfer and translation of research findings, technologies, and information into highly effective prevention practices and products which are adopted in the workplace.
The goal of r2p is to increase workplace use of effective NIOSH and NIOSH-funded research findings. NIOSH continues to work with our partners to focus research on ways to develop effective products, translate research findings into practice, target dissemination efforts, and evaluate and demonstrate the effectiveness of these efforts in improving worker health and safety.
Silicosis training in Zambia
In January 2006, a NIOSH team from the Division of Respiratory Disease Studies provided technical assistance to the Zambian National Institute for Scientific and Industrial Research (NISIR) through a training of occupational healthcare providers in Kitwe, Zambia. The assistance will help build capacity in Zambia for monitoring respiratory health, diagnosis, and medical management of miners who work in Zambian copper mines. The training reflected NIOSH's role as a World Health Organization (WHO) Collaborating Center in Occupational Health, and a partner in an International Labor Organization (ILO) / WHO global program to eliminate the incurable but preventable work-related disease of silicosis. The NIOSH team presented training in skills and procedures that are key for identifying potential incidences of work-related silicosis in time to provide effective interventions. This is an example of sharing the results of research to practice from the U.S. to Zambia.
India Silicosis Prevention
In January 2006, in response to a request from the National Institute of Occupational Health (NIOH), Indian Council of Medical Research, NIOSH Mining Engineer Andrew Cecala traveled to Beawar, India to provide technical assistance and information for preventing silicosis among workers (including women employees) from potential exposures to respirable silica dusts. Assistance included suggestions for cost-effective engineering control techniques, many of which were developed by NIOSH and directly applicable to these operations. He also participated in an Indo-U.S. Workshop, providing an overview of the NIOSH silica dust control research program and the various components of silicosis prevention. Information exchange through this cooperative working relationship will continue into the future to assist in reducing silicosis among the mining workforces in India and the United States. Further information about this project is available from Andrew Cecala. Findings and recommendations from NIOSH’s program of silicosis prevention research are available on the NIOSH Silica topic page.
Americas Plan to Eliminate Silicosis
The Ministry of Health in Chile requested technical assistance from NIOSH to strengthen capacity in order that the country can provide leadership in carrying out a National Plan to Eliminate Silicosis and to assist other countries in the region, in the framework of the ILO / WHO Global Program for the Elimination of Silicosis in the World by the year 2030. NIOSH professionals are sharing knowledge, development of methodologies for control of silica exposures, laboratory techniques for measuring silica, advice on surveillance systems, experience with the NIOSH respiratory protection program, training courses, apprenticeships of Chilean professionals at NIOSH, and visits by NIOSH professionals to Chile to work with colleagues. The exposure situations of special interest include the Mining Sector, the Arid Sectors, Stone Craftsmanship, and Dental Laboratories. NIOSH continues to work with partners in the Americas to share successful interventions, trainings and materials with the countries in the Americas.
- National Institute for Occupational Safety and Health (NIOSH)
- Centers for Disease Control and Prevention
TTY: (888) 232-6348
- New Hours of Operation
- Contact CDC-INFO